Crinecerfont
NBI-74788-CAH2011
Phase 3 small_molecule active
Quick answer
Crinecerfont for Congenital Adrenal Hyperplasia is a Phase 3 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 4 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Congenital Adrenal Hyperplasia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active